BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18446492)

  • 1. Influence of compression force on the behavior of mucoadhesive buccal tablets.
    Perioli L; Ambrogi V; Giovagnoli S; Blasi P; Mancini A; Ricci M; Rossi C
    AAPS PharmSciTech; 2008; 9(1):274-81. PubMed ID: 18446492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation.
    El-Nabarawi MA; Ali AA; Aboud HM; Hassan AH; Godah AH
    Drug Des Devel Ther; 2016; 10():4031-4045. PubMed ID: 28008227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polyvinyl alcohols as mucoadhesive polymers for mucoadhesive buccal tablets prepared by direct compression.
    Ikeuchi-Takahashi Y; Ishihara C; Onishi H
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1489-1500. PubMed ID: 28423953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.
    Kassem MA; Elmeshad AN; Fares AR
    Int J Pharm; 2014 Mar; 463(1):68-80. PubMed ID: 24412520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson's disease: physical characterization and ex vivo drug permeation through buccal mucosa.
    Çelik B; Özdemir S; Barla Demirkoz A; Üner M
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1836-1845. PubMed ID: 28665152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of buccoadhesive controlled release tablets of lercanidipine.
    Charde S; Mudgal M; Kumar L; Saha R
    AAPS PharmSciTech; 2008; 9(1):182-90. PubMed ID: 18446480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release from directly compressible theophylline buccal tablets.
    Boyapally H; Nukala RK; Bhujbal P; Douroumis D
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):227-33. PubMed ID: 20188529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets.
    Alur HH; Beal JD; Pather SI; Mitra AK; Johnston TP
    J Pharm Sci; 1999 Dec; 88(12):1313-9. PubMed ID: 10585228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets.
    Ceschel GC; Maffei P; Lombardi Borgia S; Ronchi C
    Drug Deliv; 2001; 8(3):161-71. PubMed ID: 11570597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride.
    Patel VM; Prajapati BG; Patel MM
    AAPS PharmSciTech; 2007 Mar; 8(1):22. PubMed ID: 17408221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets.
    Alur HH; Pather SI; Mitra AK; Johnston TP
    Pharm Dev Technol; 1999 Aug; 4(3):347-58. PubMed ID: 10434280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformulation studies of mucoadhesive tablets for carbamazepine sublingual administration.
    Perioli L; Pagano C
    Colloids Surf B Biointerfaces; 2013 Feb; 102():915-22. PubMed ID: 23124021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone mucoadhesive buccal tablets: formulation design, optimization and evaluation.
    Çelik B
    Drug Des Devel Ther; 2017; 11():3355-3365. PubMed ID: 29225461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol-loaded mucoadhesive buccal tablets: influence of various mucoadhesive polymers on drug release behavior.
    Tamilvanan S; Bangale GS; Ananthi JJ; Sivakumar V; Vinothapooshan G; Palanivelu M; Viswanathan MB
    PDA J Pharm Sci Technol; 2009; 63(3):196-206. PubMed ID: 20069792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoadhesive bilayer tablets of propranolol hydrochloride.
    Patel VM; Prajapati BG; Patel HV; Patel KM
    AAPS PharmSciTech; 2007 Sep; 8(3):E77. PubMed ID: 17915827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of probiotic orodispersible tablets using mucoadhesive polymers for buccal mucoadhesion.
    Hoffmann A; Fischer JT; Daniels R
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1753-1762. PubMed ID: 33006298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation.
    Nafee NA; Ismail FA; Boraie NA; Mortada LM
    Drug Dev Ind Pharm; 2004; 30(9):985-93. PubMed ID: 15554223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets.
    Alur HH; Pather SI; Mitra AK; Johnston TP
    Int J Pharm; 1999 Oct; 188(1):1-10. PubMed ID: 10528077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation.
    Prajapati SK; Tripathi P; Ubaidulla U; Anand V
    AAPS PharmSciTech; 2008; 9(1):224-30. PubMed ID: 18446485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac.
    Koirala S; Nepal P; Ghimire G; Basnet R; Rawat I; Dahal A; Pandey J; Parajuli-Baral K
    Heliyon; 2021 Mar; 7(3):e06439. PubMed ID: 33786387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.